These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Saying no to samples. Tsai A Med Econ; 2009 Nov; 86(22):22-4, 27. PubMed ID: 20055014 [No Abstract] [Full Text] [Related]
7. Friction and fact in the marketing of pharmaceuticals and biologics. Herrick JB J Am Vet Med Assoc; 1992 Aug; 201(4):556-7. PubMed ID: 1517128 [No Abstract] [Full Text] [Related]
9. Drug sample availability and prescribing behavior. Watts SA; Replogle WH; Noble SL; Beebe DK J Am Board Fam Pract; 2002; 15(6):509. PubMed ID: 12463301 [No Abstract] [Full Text] [Related]
10. Is your sample cabinet a danger zone? Lowes R Med Econ; 2004 May; 81(9):45-8. PubMed ID: 15164646 [No Abstract] [Full Text] [Related]
11. Most drug freebies go to well-off: study. Research suggests race, gender a factor, too, but drug group calls research flawed. Rhea S Mod Healthc; 2008 Jan; 38(1):12-3. PubMed ID: 18273965 [No Abstract] [Full Text] [Related]
12. Using drug samples can hinder quality. Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360 [TBL] [Abstract][Full Text] [Related]
13. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
14. Physicians, pharmaceutical representatives, and patients: who really benefits? Westfall JM J Fam Pract; 2000 Sep; 49(9):817-9. PubMed ID: 11032206 [No Abstract] [Full Text] [Related]
15. The final sampling regulations of the Prescription Drug Marketing Act are alive and well: is your sampling program compliant? Romanski JA Food Drug Law J; 2003; 58(4):649-60. PubMed ID: 15027455 [No Abstract] [Full Text] [Related]
16. Is your sample cupboard relevant to your practice? Spurling G; Kyle G Aust Fam Physician; 2007 Mar; 36(3):187-8, 192. PubMed ID: 17339989 [TBL] [Abstract][Full Text] [Related]
17. Marketing to the pharmacist. Zilz DA Med Mark Media; 1981 Jul; 16(7):8, 10, 14. PubMed ID: 10317131 [No Abstract] [Full Text] [Related]
18. [Pharmaceutical economics and socialist organization science. Drug marketing series. Implication of marketing in the lapse of time in drug studies]. Alcer G Pharm Prax; 1970; 8():169-73. PubMed ID: 5524906 [No Abstract] [Full Text] [Related]
19. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]